Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 3 | 324436 | IM / RA |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | N/A | UT8454CA | IM / RA |
No adverse event reported. Reporting per Moderna after a temperature excursion, vaccine remained viable after the excursion per Moderna.
peripheral neuropathy, anxiety, dislocated knuckle
left ulnar nerve compression, chronic bilateral low back pain without sciatica, cogwheel rigidity, seizure disorder, anal/rectal pain, tooth pain, lower abdominal pain, chemotherapy-induced neuropathy, chronic pancreatitis, pseudocyst of pancreas, controlled type 2 DM, cataract, centribular emphysema, right upper lobe pulmonary nodule, COPD, malignant neoplasm of anus, adenomatous polyp of colon, alcoholic liver disease, prostate disease, alcohol use disorder, avoidant personality disorder, cannabis use disorder, anxiety, tobacco dependence, psychogenic nonepileptic seizure, depression-major, thrombocytopenia, cognitive impairment, severe protein-calorie malnutrition, iron deficiency anemia due to chronic blood loss
epinephrine, zolpidem, loperamide, lacosamide, albuterol HFA, propranolol LA, tiotropium-olodaterol
aspirin, bee sting, nsaids, prednisolone
N/A